Mirum Pharmaceuticals, Inc. (MIRM) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -228.76M | 6.07M | 39.68M | 12.04M | -1.96M | -5.07M | 3.98M | -3.8M | 15.21M | -16.62M | -18.22M | -17.33M | -18.77M | -34.27M | -26.02M | -20.17M | -39.67M | -33.15M | -34.2M | -40.2M |
| Operating CF Margin % | - | 4.07% | 29.83% | 9.42% | -1.76% | -5.1% | 4.41% | -4.88% | 21.98% | -23.89% | -38.18% | -46.22% | -59.42% | -122.81% | -138.58% | -115.37% | -307.7% | -1056.31% | -684.04% | -365.45% |
| Operating CF Growth % | -11565.63% | 219.71% | 896.01% | 416.59% | -112.89% | 69.5% | 121.86% | 78.06% | 181.03% | 51.51% | 29.99% | 14.08% | 52.67% | -3.39% | 23.91% | 49.82% | -57.35% | 8.63% | -95.99% | -136.55% |
| Net Income | -790.15M | -5.73M | 2.9M | -5.86M | -14.68M | -23.79M | -14.23M | -24.64M | -25.28M | -35.66M | -23.59M | -74.04M | -30.13M | -36.43M | -35.71M | -26.92M | -36.61M | 57.55M | -47.11M | -43.89M |
| Depreciation & Amortization | 6.87M | 6.07M | 6.06M | 6.06M | 6.05M | 6.06M | 6.05M | 5.85M | 5.66M | 5.49M | 2.66M | 1.34M | 1.34M | 1.33M | 1.1M | 705K | 443K | 437K | 178K | 175K |
| Stock-Based Compensation | 0 | 19.03M | 18.13M | 18.47M | 15.8M | 13.25M | 11.91M | 11.84M | 11.45M | 9.72M | 8.38M | 8.36M | 8.56M | 6.9M | 6.73M | 6.82M | 6.56M | 5.56M | 7.42M | 4.82M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.58M | 0 | 1.09M | 0 | 0 |
| Other Non-Cash Items | 452.3M | 704K | 442K | -67K | 2.16M | 1.1M | 1.49M | 1.58M | -565K | 14.69M | -37K | 50.51M | 4.09M | 2.89M | 3.67M | 2.29M | 3.73M | -104.23M | 4.25M | 6.02M |
| Working Capital Changes | 102.22M | -14.01M | 12.14M | -6.56M | -11.3M | -1.68M | -1.23M | 1.56M | 23.94M | -10.87M | -5.64M | -3.5M | -2.63M | -8.96M | -1.82M | 3.52M | -13.8M | 6.45M | 1.06M | -7.32M |
| Change in Receivables | -12.89M | -19.01M | -3.15M | -9.07M | -16.83M | -10.86M | -8.1M | -5.43M | 12.97M | -20.13M | -12.51M | -10.66M | -667K | -7.66M | -2.35M | -6.12M | -4.61M | 495K | 0 | 0 |
| Change in Inventory | -1.92M | -2.28M | -1.16M | -2.33M | -2.67M | -214K | -903K | -1.08M | -964K | -2.19M | -439K | -989K | -778K | 598K | -2.8M | -1.18M | -67K | -495K | 0 | 0 |
| Change in Payables | 57.24M | 3.44M | 24.35M | 10.58M | 11.74M | 9.34M | 12.75M | 6.94M | 11.28M | 12.53M | 10.29M | 9.18M | -1.21M | -5K | 6.83M | 8.89M | -8.07M | 9.02M | 3.78M | -7.37M |
| Cash from Investing | -11.57M | 1.01M | -2.23M | -6.6M | -16.13M | 641K | -18.04M | -72.72M | -13K | -2M | -182.76M | 50.55M | 27.02M | 26.76M | -79.53M | 23.97M | 36.5M | 108.02M | -2.24M | -24.45M |
| Capital Expenditures | -10.66M | -600K | -187K | -126K | -41K | -20K | -181K | -779K | -13K | -5M | 0 | -68K | -41K | -242K | -19K | -17K | 0 | -19M | -18K | 0 |
| CapEx % of Revenue | - | 0.4% | 0.14% | 0.1% | 0.04% | 0.02% | 0.2% | 1% | 0.02% | 7.19% | - | 0.18% | 0.13% | 0.87% | 0.1% | 0.1% | - | 605.58% | 0.36% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.99M | 0 | -19M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -10M | -10M | 0 | 0 | -212.76M | 0 | -15M | 0 | 0 | 23.99M | 0 | 127M | 0 | 0 |
| Cash from Financing | 270.08M | 9M | 16.1M | 8.69M | 6.36M | 5.34M | 3.86M | 7.29M | 1.21M | 1.78M | 207.13M | 114.71M | 12.99M | -329K | 86.07M | 5.25M | 18.1M | 615K | 345K | 65.91M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 270.08M | 9M | 16.1M | 8.69M | 0 | 0 | 0 | 0 | 0 | -159K | 202.36M | 0 | 14.48M | -280K | 86.36M | 3.9M | 17.38M | 735K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 6.36M | 5.34M | 3.86M | 7.29M | 1.21M | 1.94M | 4.77M | 114.71M | -1.49M | -49K | -292K | 1.34M | 720K | -120K | 345K | 65.91M |
| Net Change in Cash | 28.22M | 15.66M | 53.9M | 16.36M | -10.68M | -466K | -10.1M | -69.35M | 16.52M | -16.73M | 5.83M | 147.81M | 21.42M | -7.76M | -19.51M | 9M | 14.93M | 75.5M | -36.09M | 1.26M |
| Free Cash Flow | -229.43M | 5.47M | 39.49M | 11.91M | -2M | -5.09M | -6.2M | -14.58M | 15.2M | -21.62M | -18.22M | -17.4M | -33.81M | -34.51M | -26.04M | -20.19M | -39.67M | -52.15M | -34.22M | -40.2M |
| FCF Margin % | - | 3.67% | 29.69% | 9.32% | -1.79% | -5.12% | -6.86% | -18.72% | 21.96% | -31.08% | -38.18% | -46.4% | -107.02% | -123.67% | -138.68% | -115.47% | -307.7% | -1661.89% | -684.4% | -365.45% |
| FCF Growth % | -11359.89% | 207.45% | 737.31% | 181.7% | -113.17% | 76.46% | 65.99% | 16.19% | 144.95% | 37.36% | 30.04% | 13.82% | 14.76% | 33.82% | 23.89% | 49.78% | -57.34% | -43.64% | -95.58% | -135.81% |
| FCF per Share | -3.90 | 0.11 | 0.69 | 0.24 | -0.04 | -0.11 | -0.13 | -0.31 | 0.32 | -0.46 | -0.44 | -0.46 | -0.90 | -0.92 | -0.75 | -0.63 | -1.27 | -1.71 | -1.13 | -1.33 |
| FCF Conversion (FCF/Net Income) | 0.29x | -1.06x | 13.66x | -2.05x | 0.13x | 0.21x | -0.28x | 0.15x | -0.60x | 0.47x | 0.77x | 0.23x | 0.62x | 0.94x | 0.73x | 0.75x | 1.08x | -0.58x | 0.73x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 6.33M | 583K | 6.33M | 0 | 6.04M | 289K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 1.49M | 162K | 233K | 432K | 200K | 139K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |